Philips Healthcare’s Moneshia zu Eltz discusses future of digital health at
OurCrowd’s Global Investor Summit 2016

“This quote needs to counter any objections people might have using the product.”

JOHN SMITH

Highlight The Features

Add some more descriptive content here to define your feature offering and how it contributes to the overall experience.

Feature One

Clearly outline this features importance and relevance.

Feature Two

Feature Three

Clearly outline this features importance and relevance.

Feature Four

Clearly outline this features importance and relevance.

What People Are Saying About Voyage

“This quote needs to nudge people toward a conversion by establishing trust.”

JANE SMITH

A very clear closing argument statement of your offer.

Zu Eltz describes Philips Healthcare’s
Partnership & Collaboration Model

OurCrowd Portfolio Companies shaping the future of digital health

Sweetch is a smartphone platform that leverages a unique diabetes prediction engine to produce a dynamic risk-meter, which interfaces with a custom, automated coaching regimen to guide users toward lowering their risk of developing diabetes in compliance with the “Diabetes Prevention Program” (DPP).

www.sweetch.com

Sight Diagnostics is pioneering an innovative computer vision platform for cheaper, faster, and fully-automated blood diagnostics whose first application is the 300 million annual tests for Malaria worldwide. The Sight Diagnostics platform combines computer vision with patented blood-preparation techniques to count blood cells and differentiate between healthy and parasite-infected blood.
www.sightdx.com

Yossi Bahagon, Chairman, Sweetch

Seth Salpeter, Chief Science Officer, Sight Diagnostics

About

SIGN UP

Featured Content

Changing the Landscape of MedTech Investing
Duis fringilla quam a libero convallis, a lacinia metus tempus. Donec vel erat dolor. Quisque sed cursus eros.
READ MORE

Startups

Since its inception in 2013, OurCrowd and its investor community have made 91 investments totaling $200 million and ~20% of the investments made have been in medical devices, healthcare, and big data for the medical industry.

OurCrowd has more than 75 other companies in its portfolio, in e-commerce, IoT, AutoTech, AgTech, Cybersecurity, VR, Real Estate Tech, Social, and Enterprise Software

How it works

As Featured In:

Team

Dr. Morris Laster
OurCrowd Venture Partner
20 yrs of experience in biopharmaceuticals
Founder of 6 companies that have gone public in the US, UK and Israel

S. Morry Blumenfeld
Head of OurCrowd’s Medical Advisory Board
President and CEO of Quescon Consultants Former executive at GE for ~35 years Initiated CT and MRI business at GE Medical Systems.

Norbert Pelc, PhD, Sc.D.
Advisor
Boston Scientific Applied Biomedical Engineering Professor Stanford University Chair Bioengineering

Dr. Ziv Haskal, FSIR FAHA FACR
Advisor
Top Endovascular Specialist and Interventional Radiology expert Professor of Radiology, University of Virginia School of Medicine Editor-in-chief, Journal of Interventional and Vascular Radiology

Reuben Mezrich, PhD, MD, FACR
Advisor
Professor and former chair of the Departmniversity of Maryland School of Medicine

Dr. Zev Davis, M.D.
Advisor
Serves as Director of Cardiovascular Surgery of the Edward Heart Hospital in Naperville, Illinois. Dr. Davis serves as a partner in Cardiac Surgery Associates.

OurCrowd’s investment ecosystem includes a medical Venture Partner and a Medical Advisory Board, who advise, guide, and serve as board members for our MedTech portfolio. OurCrowd’s Medical Advisory Board includes:

OurCrowd's professional team is comprised of entrepreneurs, venture capitalists, investors, and geeks with decades of combined experience building businesses, raising capital, and investing in Israeli and global startups. OurCrowd’s leadership includes:

Pairing OurCrowd's investment efficiency, control, independence and dynamic early stage deal orgination with strategic and prominent venture capital firms, global corporate partners, private equity, angel groups and super-angels.

Corporate, Institutional, and Venture Capital Co-Investors include:

Co-Investors

Israel: The Ideal Ecosystem for MedTech Investing

HIL Applied Medical is developing a new class of ultra-compact, high-performance accelerators for cancer proton therapy. HIL’s patented approach to particle acceleration and beam delivery enables reduction in the size, complexity and cost of a proton therapy system. The unique properties of laser-accelerated proton beams allow for further savings in the ancillary magnetic systems used for beam shaping and delivery, while providing state-of-the-art clinical capabilities.

*OurCrowd invested $1.2 million in HIL Applied Medical in 2014

$200M

TOTAL
RAISED

91

COMPANIES
FUNDED

4,000

COMPANIES
VETTED

11,000

ACCREDITED
INVESTORS

110

COUNTRIES
REPRESENTED

Iron dome missile defense technology that integrates a diverse set of sensors responding with the appropriate action

$14.8M

FUNDED

Consumer-oriented optical molecular sensor

$3.7M

FUNDED

Wearable cap that visualizes the workings of the brain

$2M

FUNDED

EXITED - NASDAQ: RWLK

Giving paraplegics the ability to stand, walk and climb

$3.9M

Zu Eltz describes Philips Healthcare’s Partnership & Collaboration Model:
“…Connecting the dots is really what this is about in terms of the future of healthcare… This [is] not a continuum that any one company is going to be able to own or drive. [Philips] is collaborating… with the best of breed and the best of suite, with Amazon, with Salesforce, and with innovators that can build the apps…”

“Healthcare is personal,” Zu Eltz affirmed as she addressed the audience of thousands of investors, “it’s about… our individual health, the health of friends and family, [and] people that we live with.” Following Zu Eltz’s opening statements, the panel of startups that presented (see below) continued in the light of Philips Healthcare’s universal and impactful investment theme of “the promise of healthcare for all and population health, as well ‘our individual health.”

“With technology we’re at the cusp of the promise of changing healthcare and the way that it’s practiced in the future.” –Monesha Zu Eltz, VP Strategic Alliance and Partnering at Philips

Learn more about how to become part of the MedTech investment landscape, and how to invest in game-changing startups through OurCrowd.

Access pre-vetted startup investment opportunities.

Perform self-guided investment research with curated diligence materials.

Invest alongside trusted venture capital and angel investors.

How do I invest in
Healthcare Startups ?

Hand-picked startup investments

Medical Advisory Board

Core Leadership

Jonathan Medved
Founder and CEO
Jonathan Medved is according to the Washington Post, ”one of Israel’s leading high tech venture capitalists”. In the September, 2008 NY Times Supplement “Israel at 60” Medved was named one of the top 10 most influential Americans who have impacted Israel.

Elan Zivotofsky
Head of Investments
15 years’ experience in Israeli investing as Managing Partner at Prelude Israel, head of technology banking at Lehman Brothers Israel and tech research analyst for Goldman Sachs

Pini Lozowick
General Partner and Chief Investment Officer
Serial entrepreneur, angel investor and venture capitalist, Previously general partner at Alta Berkeley, Director of Marketing at Broadcom, Chairman of Provigent, and founder and GM of Verisense

David Stark
Partner, Investments
Previously investment analyst at Blackstone in Real Estate PE Group

Gadi Mazor
General Partner and CTO
Serial entrepreneur, founding three startups in character and voice recognition and wireless communications
Previously sat on RIM (Blackberry) advisory board, and served on the US Senate committee that defined the US public alert system

Shai Ben Tovim
Partner and Chief Product Officer
Previously Head of Product at Wonga.com, President of R&D and Corp VP of Strategy at Alvarion

Joel Maryles
Venture Partner and Chief Exit Officer
Previously established and managed the Israeli investment banking operations for Citigroup/Salomon Smith Barney and ran it for over a decade, completing 60+ successful transactions including IPOs, private placements, debt offerings and mergers and acquisitions

Janine Kutliroff
Chief Client Officer
Previously founder and CEO of Omek Interactive, acquired by Intel, CEO of IDT Global Israel

Accelerating Investment in Digital Health

Zebra Medical Vision is an Israeli startup whose machine vision technology enables healthcare providers to make diagnostic decisions faster, more accurately and for less money. Zebra is led by a founding team that includes Eyal Gura, who has sold startups to eBay, Getty Images and others, Elad Benjamin, who brings decades of executive experience at medical information management companies, and Eyal Toledano, who ran Samsung's Israel R&D operations.

Elad Benjamin, CEO Zebra Medical Vision

Sweetch is a smartphone platform that leverages a unique diabetes prediction engine to produce a dynamic risk-meter, which interfaces with a custom, automated coaching regimen to guide users toward lowering their risk of developing diabetes in compliance with the “Diabetes Prevention Program” (DPP).

Yossi Bahagon, Chairman, Sweetch

Sight Diagnostics is pioneering an innovative computer vision platform for cheaper, faster, and fully-automated blood diagnostics whose first application is the 300 million annual tests for Malaria worldwide. The Sight Diagnostics platform combines computer vision with patented blood-preparation techniques to count blood cells and differentiate between healthy and parasite-infected blood.

Philips' Head of Strategic Partnerships discusses working with startups

Since its inception in 2013, OurCrowd and its investor community have made 91 investments totaling $200 million -- and ~20% of the investments made have been in medical devices, healthcare, and big data for the medical industry.

Seth Salpeter, Chief Science Officer, Sight Diagnostics

Accelerating Investment in Digital Health: Philips' Head of Strategic Partnerships discusses working with startups

Predicting and Preventing Diabetes at Scale

Global startups that are building the tech that will power our future

Discover and Invest in Tech Startups

Founder Seeking Capital? Click Here

Innovative technology bringing lung-function testing to the desktop

$1.4M

FUNDED

Hand-picked
Professionally-vetted startups

Co-invest

Reinventing the sports viewing experience with Free-Dimensional Video

$2.2M

AQUIRED BY INTEL

Software solution that enables surgeons to practice complex neurosurgery

$1.7M

FUNDED

Location of things platform that accurately finds and organizes things

$1.4M

FUNDED

+150
more

SIGN UP

About

Today’s biggest returns are going to early investors in private companies, especially high-growth technology companies that are changing nearly every aspect of life. Rather than wait for a company to go public, often at a high price, OurCrowd’s equity crowdfunding platform allows investors exclusive opportunities to buy stakes in private startup companies for as little as $10,000.

The graph below shows how the days of seeing 600% returns in public technology companies are largely over, with such opportunities confined to private investments.

Almost all the returns are now private
Create bar charts

$220M

93

COMPANIES FUNDED

TOTAL RAISED

ACCREDITED INVESTORS

12,000

AS FEATURED IN

*Accredited Investors only

+120
more

OurCrowd invites individual investors from around the world to become part of Israel's legendary innovation. We offer numerous exclusive opportunities to participate in this rapidly expanding high-tech ecosystem.

COMPANIES FUNDED

TOTAL RAISED

ACCREDITED INVESTORS

12,000

110

COUNTRIES REPRESENTED

All of our companies are hand-picked startups, backed by some of the most respected venture-capital firms and angel investors.

$220M

93

4,000

COMPANIES VETTED

Why Startups?

Why Startups?

Early-stage Investment Opportunities

Alongside trusted venture capital and angel investors

Source: Andreesen Horowitz. Recreated from slide 30 of "U.S. Technology funding -- What's Going On?"